Resilience mechanisms in Parkinson’s disease: a domain-specific conceptual framework
Brain · 15.09.2026
DOI: 10.1093/brain/awag310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 15.09.2026. Verfasst von Marina C Ruppert-Junck und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Marburg University, D-35043 Marburg, Germany. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: EU Joint Programme—Neurodegenerative Disease Research, German Federal Ministry of Education and Research, Netherlands Organization for Health Research and Development.
Abstract (Originalsprache)
While nigrostriatal dopaminergic cell loss is the pathological hallmark of Parkinson’s disease, it is well-known that dopamine deficiency cannot fully explain the clinical severity or disease progression. Emerging data suggest that resilience, i.e. the brain’s capacity to maintain function despite pathology, plays a key role in shaping clinical variability of both motor and non-motor symptoms. However, different contributing terms have been proposed, including brain compensation and reserve, and it remains unclear how these terms can be delineated both conceptually and mechanistically. Therefore, here we provide a synthesis of recent neuroimaging evidence on resilience mechanisms in Parkinson’s disease, with the following aims: (i) clarify the terminology; (ii) define the mechanisms; and (iii) relate resilience mechanisms to treatments, including dopamine replacement therapy and deep brain stimulation. We distinguish between compensation and reserve. We define compensation as adaptive neural activity that stabilizes task performance in the presence of pathology, particularly under increased demands, and is inversely related to clinical deficits. By contrast, reserve (cognitive or motor) refers to the capacity of neural resources that is built up across the lifetime, shaped by factors of an individual’s exposome. Compensation has been localized to the parieto-premotor network alongside the relatively preserved anterior striatum. Higher motor reserve has been linked to somatomotor network tolerance, preserved structural integrity and higher striatal functional network connectivity. Cognitive reserve relates to network robustness and structural integrity within the fronto-parietal network. Whether resilience mechanisms drive interindividual variability in long-term treatment response remains unresolved. Lower motor reserve predicts accelerated levodopa dose escalation and increased risk of dyskinesias, while cognitive reserve modulates both cognitive and motor outcomes after deep brain stimulation, highlighting cross-domain interactions. Brain compensation and reserve are two key components of resilience that together shape clinical heterogeneity in Parkinson’s disease across motor and cognitive domains. Although they operate at different timescales and through distinct mechanisms, they remain intrinsically related. Our framework suggests that biomarkers of resilience could complement biological definitions of Parkinson’s disease and shift therapeutic strategies from merely slowing degeneration towards strengthening adaptive capacity. Key priorities for future work are to define the longitudinal relationship between resilience failure and subcortical neurodegeneration using concurrent measures of nigrostriatal decline, multimodal datasets or controlled interventions, and to determine how symptom domain-specific resilience mechanisms shape treatment outcomes to enable targeted modulation and better capture disease heterogeneity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Marburg University, D-35043 Marburg, Germany.
- Center for Mind, Brain and Behavior, Universities of Giessen and Marburg, D-35043 Marburg, Germany.
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Nuclear Medicine, D-50937 Cologne, Germany.
- Research Centre Juelich, Institute for Neuroscience and Medicine II (INM-II), Molecular Organization of the Brain, D-52425 Juelich, Germany.
- Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, 6525 EN Nijmegen, The Netherlands.
- Paris Brain Institute, Movement Investigations and Therapeutics Team (MOV'IT), Center for NeuroImaging Research (CENIR), Sorbonne University, Pitié-Salpêtrière Hospital, 75013 Paris, France.
ORCID-Profile: Marina C Ruppert-Junck, Thilo van Eimeren, Rick C Helmich, Martin E Johansson, David Pedrosa
Förderung
- EU Joint Programme—Neurodegenerative Disease Research
- German Federal Ministry of Education and Research
- Netherlands Organization for Health Research and Development
- Ministry of Education
- Youth and Sports of the Czech Republic
- Swedish Research Council
Zitieren
APA
Ruppert-Junck, M. C., van Eimeren, T., Giehl, K., Helmich, R. C., Hönig, M., Johansson, M. E., Mitterová, K., Rektorová, I., Waldthaler, J., Pedrosa, D., TRACE-PD consortium, & the (2026). Resilience mechanisms in Parkinson’s disease: a domain-specific conceptual framework. Brain. https://doi.org/10.1093/brain/awag310
Vancouver
Ruppert-Junck MC, van Eimeren T, Giehl K, Helmich RC, Hönig M, Johansson ME, et al. Resilience mechanisms in Parkinson’s disease: a domain-specific conceptual framework. Brain. 2026. doi:10.1093/brain/awag310
BibTeX
@article{RuppertJunck2026,
author = {Ruppert-Junck, Marina C and van Eimeren, Thilo and Giehl, Kathrin and Helmich, Rick C and Hönig, Merle and Johansson, Martin E and Mitterová, Kristína and Rektorová, Irena and Waldthaler, Josefine and Pedrosa, David and TRACE-PD consortium, TRACE-PD consortium and the, the},
title = {Resilience mechanisms in Parkinson’s disease: a domain-specific conceptual framework},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awag310}
}
EUVIMED